866-997-4948(US-Canada Toll Free)

Global Brand Drugs Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Sep 2018

Category :

Pharmaceutical

No. of Pages : 124 Pages

This report studies the global market size of Brand Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Brand Drugs in these regions.
This research report categorizes the global Brand Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Amedication(also referred to asmedicine,pharmaceutical drug, or simplydrug) is adrugused todiagnose,cure,treat, orpreventdisease.Drug therapy (pharmacotherapy) is an important part of themedical fieldand relies on the science ofpharmacologyfor continual advancement and onpharmacyfor appropriate management.
In 2017, the global Brand Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Brand Drugs market based on company, product type, application and key regions.

The various contributors involved in the value chain of Brand Drugs include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Brand Drugs include
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Shire
Boehringer Ingelheim
Takeda

Market Size Split by Type
Biopharmaceutical
Chemistry Medicine
Market Size Split by Application
Hospital
Clinic
Other

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Brand Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Brand Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Brand Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Brand Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Brand Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Brand Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Brand Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Brand Drugs Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Brand Drugs Market Size Growth Rate by Type
1.4.2 Biopharmaceutical
1.4.3 Chemistry Medicine
1.5 Market by Application
1.5.1 Global Brand Drugs Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Brand Drugs Market Size
2.1.1 Global Brand Drugs Revenue 2016-2025
2.1.2 Global Brand Drugs Sales 2016-2025
2.2 Brand Drugs Growth Rate by Regions
2.2.1 Global Brand Drugs Sales by Regions
2.2.2 Global Brand Drugs Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Brand Drugs Sales by Manufacturers
3.1.1 Brand Drugs Sales by Manufacturers
3.1.2 Brand Drugs Sales Market Share by Manufacturers
3.1.3 Global Brand Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Brand Drugs Revenue by Manufacturers
3.2.1 Brand Drugs Revenue by Manufacturers (2016-2018)
3.2.2 Brand Drugs Revenue Share by Manufacturers (2016-2018)
3.3 Brand Drugs Price by Manufacturers
3.4 Brand Drugs Manufacturing Base Distribution, Product Types
3.4.1 Brand Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Brand Drugs Product Category
3.4.3 Date of International Manufacturers Enter into Brand Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Brand Drugs Sales by Type
4.2 Global Brand Drugs Revenue by Type
4.3 Brand Drugs Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Brand Drugs Breakdown Data by Application

6 North America
6.1 North America Brand Drugs by Countries
6.1.1 North America Brand Drugs Sales by Countries
6.1.2 North America Brand Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Brand Drugs by Type
6.3 North America Brand Drugs by Application
6.4 North America Brand Drugs by Company

7 Europe
7.1 Europe Brand Drugs by Countries
7.1.1 Europe Brand Drugs Sales by Countries
7.1.2 Europe Brand Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Brand Drugs by Type
7.3 Europe Brand Drugs by Application
7.4 Europe Brand Drugs by Company

8 Asia Pacific
8.1 Asia Pacific Brand Drugs by Countries
8.1.1 Asia Pacific Brand Drugs Sales by Countries
8.1.2 Asia Pacific Brand Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Brand Drugs by Type
8.3 Asia Pacific Brand Drugs by Application
8.4 Asia Pacific Brand Drugs by Company

9 Central & South America
9.1 Central & South America Brand Drugs by Countries
9.1.1 Central & South America Brand Drugs Sales by Countries
9.1.2 Central & South America Brand Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Brand Drugs by Type
9.3 Central & South America Brand Drugs by Application
9.4 Central & South America Brand Drugs by Company

10 Middle East and Africa
10.1 Middle East and Africa Brand Drugs by Countries
10.1.1 Middle East and Africa Brand Drugs Sales by Countries
10.1.2 Middle East and Africa Brand Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Brand Drugs by Type
10.3 Middle East and Africa Brand Drugs by Application
10.4 Middle East and Africa Brand Drugs by Company

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Brand Drugs
11.1.4 Brand Drugs Product Description
11.1.5 Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Brand Drugs
11.2.4 Brand Drugs Product Description
11.2.5 Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Brand Drugs
11.3.4 Brand Drugs Product Description
11.3.5 Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Brand Drugs
11.4.4 Brand Drugs Product Description
11.4.5 Recent Development
11.5 Merck & Co. (MSD)
11.5.1 Merck & Co. (MSD) Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Brand Drugs
11.5.4 Brand Drugs Product Description
11.5.5 Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Brand Drugs
11.6.4 Brand Drugs Product Description
11.6.5 Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Brand Drugs
11.7.4 Brand Drugs Product Description
11.7.5 Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Brand Drugs
11.8.4 Brand Drugs Product Description
11.8.5 Recent Development
11.9 GlaxoSmithKline (GSK)
11.9.1 GlaxoSmithKline (GSK) Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Brand Drugs
11.9.4 Brand Drugs Product Description
11.9.5 Recent Development
11.10 Amgen
11.10.1 Amgen Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Brand Drugs
11.10.4 Brand Drugs Product Description
11.10.5 Recent Development
11.11 AstraZeneca
11.12 Bristol-Myers Squibb
11.13 Eli Lilly
11.14 Teva
11.15 Bayer
11.16 Novo Nordisk
11.17 Allergan
11.18 Shire
11.19 Boehringer Ingelheim
11.20 Takeda

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Brand Drugs Raw Material
13.1.2 Brand Drugs Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Brand Drugs
Figure Global Brand Drugs Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Brand Drugs Production Market Share by Types (Product Category) in 2017
Figure Biopharmaceutical Product Picture
Table Major Manufacturers of Biopharmaceutical
Figure Chemistry Medicine Product Picture
Table Major Manufacturers of Chemistry Medicine
Table Global Brand Drugs Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Hospital
Figure Clinic
Figure Other
Figure Brand Drugs Report Years Considered
Figure Global Brand Drugs Market Size 2016-2025 (Million US$)
Figure Global Brand Drugs Sales 2016-2025 (K Units)
Table Global Brand Drugs Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Brand Drugs Sales by Regions 2016-2025 (K Units)
Table Global Brand Drugs Sales Market Share by Regions 2016-2025
Figure Global Brand Drugs Sales Market Share by Regions 2016-2025
Figure 2017 Global Brand Drugs Sales Market Share by Regions
Table Global Brand Drugs Revenue by Regions 2016-2025 (Million US$)
Table Global Brand Drugs Revenue Market Share by Regions 2016-2025
Figure Global Brand Drugs Revenue Market Share by Regions 2016-2025
Figure 2017 Global Brand Drugs Revenue Market Share by Regions
Table Global Brand Drugs Sales by Manufacturers (2016-2018) (K Units)
Table Global Brand Drugs Sales Share by Manufacturers (2016-2018)
Figure Global Brand Drugs Sales Share by Manufacturers in 2017
Table Brand Drugs Revenue by Manufacturers (2016-2018) (Million US$)
Table Brand Drugs Revenue Share by Manufacturers (2016-2018)
Figure Brand Drugs Value Share by Manufacturers in 2017
Table Global Brand Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Brand Drugs Price (2016-2018) (USD/Unit)
Table Brand Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Brand Drugs Product Category
Table Date of International Manufacturers Enter into Brand Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Brand Drugs Sales by Type (2016-2025) (K Units)
Table Global Brand Drugs Sales Share by Type (2016-2025)
Figure Global Brand Drugs Sales Market Share by Type (2016-2025)
Figure Global Brand Drugs Sales Market Share by Type in 2017
Table Global Brand Drugs Revenue by Type (2016-2025) (Million US$)
Table Global Brand Drugs Revenue Share by Type (2016-2025)
Figure Global Brand Drugs Revenue Market Share by Type (2016-2025)
Figure Global Brand Drugs Revenue Market Share by Type in 2017
Table Brand Drugs Price by Type 2013-2018 (USD/Unit)
Table Global Brand Drugs Sales by Application (2016-2025) (K Units)
Table Global Brand Drugs Sales Share by Application (2016-2025)
Figure Global Sales Brand Drugs Market Share by Application (2016-2025)
Figure Global Sales Brand Drugs Market Share by Application (2016-2025)
Figure North America Brand Drugs Sales Growth Rate 2016-2025 (K Units)
Figure North America Brand Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table North America Brand Drugs Sales by Countries (2016-2025) (K Units)
Table North America Brand Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 North America Brand Drugs Sales Market Share by Countries
Table North America Brand Drugs Revenue by Countries (2016-2025) (Million US$)
Table North America Brand Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Brand Drugs Revenue Market Share by Countries
Figure United States Brand Drugs Sales Growth Rate (2016-2025) (K Units)
Figure United States Brand Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Brand Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Canada Brand Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Brand Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Brand Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table North America Brand Drugs Sales by Type (2016-2025) (K Units)
Table North America Brand Drugs Sales Market Share by Type (2016-2025)
Figure 2017 North America Brand Drugs Market Share by Type
Table North America Brand Drugs Sales by Application (2016-2025) (K Units)
Table North America Brand Drugs Sales Market Share by Application (2016-2025)
Figure 2017 North America Brand Drugs Market Share by Application
Table North America Brand Drugs Sales by Company (2016-2018) (K Units)
Table North America Brand Drugs Sales Market Share by Company (2016-2018)
Figure North America Brand Drugs Sales Market Share by Company in 2017
Figure Europe Brand Drugs Sales Growth Rate 2016-2025 (K Units)
Figure Europe Brand Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Brand Drugs Sales by Countries (2016-2025) (K Units)
Table Europe Brand Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Brand Drugs Sales Market Share by Countries
Table Europe Brand Drugs Revenue by Countries (2016-2025) (Million US$)
Table Europe Brand Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Brand Drugs Revenue Market Share by Countries
Figure Germany Brand Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Germany Brand Drugs Revenue Growth Rate (2016-2025) (K Units)
Figure France Brand Drugs Sales Growth Rate (2016-2025) (K Units)
Figure France Brand Drugs Revenue Growth Rate (2016-2025) (K Units)
Figure UK Brand Drugs Sales Growth Rate (2016-2025) (K Units)
Figure UK Brand Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Brand Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Italy Brand Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Brand Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Russia Brand Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Brand Drugs Sales by Type (2016-2025) (K Units)
Table Europe Brand Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Europe Brand Drugs Market Share by Type
Table Europe Brand Drugs Sales by Application (2016-2025) (K Units)
Table Europe Brand Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Europe Brand Drugs Market Share by Application
Table Europe Brand Drugs Sales by Company (2016-2018) (K Units)
Table Europe Brand Drugs Sales Market Share by Company (2016-2018)
Figure Europe Brand Drugs Sales Market Share by Company in 2017
Figure Asia Pacific Brand Drugs Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Brand Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Brand Drugs Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Brand Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Brand Drugs Sales Market Share by Countries
Table Asia Pacific Brand Drugs Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Brand Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Brand Drugs Revenue Market Share by Countries
Figure China Brand Drugs Sales Growth Rate (2016-2025) (K Units)
Figure China Brand Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Brand Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Japan Brand Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Brand Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Korea Brand Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure India Brand Drugs Sales Growth Rate (2016-2025) (K Units)
Figure India Brand Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Brand Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Australia Brand Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Brand Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Brand Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Brand Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Brand Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Brand Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Brand Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Brand Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Brand Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Brand Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Brand Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Brand Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Brand Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Brand Drugs Sales by Type (2016-2025) (K Units)
Table Asia Pacific Brand Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Brand Drugs Market Share by Type
Table Asia Pacific Brand Drugs Sales by Application (2016-2025) (K Units)
Table Asia Pacific Brand Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Brand Drugs Market Share by Application
Table Asia Pacific Brand Drugs Sales by Company (2016-2018) (K Units)
Table Asia Pacific Brand Drugs Sales Market Share by Company (2016-2018)
Figure Asia Pacific Brand Drugs Sales Market Share by Company in 2017
Figure Central & South America Brand Drugs Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Brand Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Brand Drugs Sales by Countries (2016-2025) (K Units)
Table Central & South America Brand Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Brand Drugs Sales Market Share by Countries
Table Central & South America Brand Drugs Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Brand Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Brand Drugs Revenue Market Share by Countries
Figure Brazil Brand Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Brand Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Brand Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Brand Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Brand Drugs Sales by Type (2016-2025) (K Units)
Table Central & South America Brand Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Brand Drugs Market Share by Type
Table Central & South America Brand Drugs Sales by Application (2016-2025) (K Units)
Table Central & South America Brand Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Brand Drugs Market Share by Application
Table Central & South America Brand Drugs Sales by Company (2016-2018) (K Units)
Table Central & South America Brand Drugs Sales Market Share by Company (2016-2018)
Figure Central & South America Brand Drugs Sales Market Share by Company in 2017
Figure Middle East and Africa Brand Drugs Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Brand Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Brand Drugs Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Brand Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Brand Drugs Sales Market Share by Countries
Table Middle East and Africa Brand Drugs Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Brand Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Brand Drugs Revenue Market Share by Countries
Figure GCC Countries Brand Drugs Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Brand Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Brand Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Brand Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Brand Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Brand Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Brand Drugs Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Brand Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Brand Drugs Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Brand Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Brand Drugs Market Share by Type
Table Middle East and Africa Brand Drugs Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Brand Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Brand Drugs Market Share by Application
Table Middle East and Africa Brand Drugs Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Brand Drugs Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Brand Drugs Sales Market Share by Company in 2017
Table Pfizer Company Details
Table Pfizer Brand Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table Roche Company Details
Table Roche Brand Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Roche Recent Development
Table Sanofi Company Details
Table Sanofi Brand Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sanofi Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Brand Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Johnson & Johnson Recent Development
Table Merck & Co. (MSD) Company Details
Table Merck & Co. (MSD) Brand Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Merck & Co. (MSD) Recent Development
Table Novartis Company Details
Table Novartis Brand Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Novartis Recent Development
Table AbbVie Company Details
Table AbbVie Brand Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table AbbVie Recent Development
Table Gilead Sciences Company Details
Table Gilead Sciences Brand Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Gilead Sciences Recent Development
Table GlaxoSmithKline (GSK) Company Details
Table GlaxoSmithKline (GSK) Brand Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table GlaxoSmithKline (GSK) Recent Development
Table Amgen Company Details
Table Amgen Brand Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Amgen Recent Development
Table AstraZeneca Company Details
Table Bristol-Myers Squibb Company Details
Table Eli Lilly Company Details
Table Teva Company Details
Table Bayer Company Details
Table Novo Nordisk Company Details
Table Allergan Company Details
Table Shire Company Details
Table Boehringer Ingelheim Company Details
Table Takeda Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Brand Drugs Value Chain
Table Typical Suppliers of Key Brand Drugs Raw Material
Table Brand Drugs Customers List
Table Brand Drugs Sales Channels
Table Brand Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *